Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol [Internet]. 2021 [cited 2025 Feb 21];14(10). Available from: https://pubmed.ncbi.nlm.nih.gov/34243011/
Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338–44.
Li D. Recent advances in colorectal cancer screening. Chronic Dis Transl Med. 2018;4(3):139–47.
PubMed PubMed Central Google Scholar
Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. preventive services task force. Ann Intern Med. 2008;149(9):638–58.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for colorectal cancer. JAMA. 2021;325(19):1965.
Jayasinghe M, Prathiraja O, Caldera D, Jena R, Coffie-Pierre JA, Silva MS, et al. Colon cancer screening methods: 2023 update. Cureus. 2023. https://doi.org/10.7759/cureus.37509
The Lancet Gastroenterology & Hepatology. Controversy over colonoscopy for colorectal cancer screening. Lancet Gastroenterol Hepatol. 2022;7(12):1061.
Triantafillidis JK, Vagianos C, Malgarinos G. Colonoscopy in colorectal cancer screening: current aspects. Indian J Surg Oncol. 2015;6(3):237–50.
PubMed PubMed Central Google Scholar
Konda A, Duffy MC. Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions. Gastroenterol Clin North Am. 2008;37(1):191–213.
Robertson DJ, Lee JK, Boland RC, Dominitz JA, Giardiello FM, Johnson DA, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112(1):37–53.
Allison J. Why what you may not know about fecal immunochemical testing matters. Ann Intern Med. 2019;170(5):342–3.
Zhong GC, Sun WP, Wan L, Hu JJ, Hao FB. Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: a systematic review and meta-analysis. Gastrointest Endosc. 2020;91(3):684-697.e15.
Singal AG, Gupta S, Skinner CS, Ahn C, Santini NO, Agrawal D, et al. Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion. JAMA. 2017;318(9):806.
Article PubMed PubMed Central Google Scholar
Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132(7):2304–12.
Sali L, Mascalchi M, Falchini M, Ventura L, Carozzi F, Castiglione G, et al. Reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trial. J Natl Cancer Inst. 2016;108(2): djv319.
González-López N, Quintero E, Gimeno-Garcia AZ, Bujanda L, Banales J, Cubiella J, et al. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: a multicenter, open-label, parallel-group, randomized trial (ParCoFit study). PLoS Med. 2023;20(10):e1004298.
PubMed PubMed Central Google Scholar
Mehta SJ, Palat S, McDonald C, Reitz C, Okorie E, Williams K, et al. A randomized trial of choice architecture and mailed colorectal cancer screening outreach in a community health setting. Clin Gastroenterol Hepatol. 2024;22(10):2117-2124.e2.
Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved. JAMA Intern Med. 2013. https://doi.org/10.1001/jamainternmed.2013.9294
Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, et al. Diagnostic yield of one-time colonoscopy vs one-time flexible sigmoidoscopy vs multiple rounds of mailed fecal immunohistochemical tests in colorectal cancer screening. Clin Gastroenterol Hepatol. 2020;18(3):667-675.e1.
Forsberg A, Westerberg M, Metcalfe C, Steele R, Blom J, Engstrand L, et al. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial. Lancet Gastroenterol Hepatol. 2022;7(6):513–21.
Forbes GM, Mendelson RM, Edwards JT, Foster NM, Pawlik JZ, Bampton PA, et al. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust. 2006;184(11):546–50.
Chen H, Lu M, Liu C, Zou S, Du L, Liao X, et al. Comparative evaluation of participation and diagnostic yield of colonoscopy vs fecal immunochemical test vs risk-adapted screening in colorectal cancer screening: interim analysis of a multicenter randomized controlled trial (TARGET-C). Am J Gastroenterol. 2020;115(8):1264–74.
Castells A, Quintero E. Programmatic screening for colorectal cancer: the COLONPREV study. Dig Dis Sci. 2015;60(3):672–80.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:n71.
Fekete JT, Győrffy B. MetaAnalysisOnline.com: an online tool for the rapid meta-analysis of clinical and epidemiological studies (Preprint). J Med Internet Res. 2024. https://doi.org/10.2196/64016
Sugerman DT. Options for colorectal cancer screening. JAMA. 2013;310(6):658.
Khan AA. Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence? J Cancer Res Clin Oncol [Internet]. 2021 [cited 2025 Feb 22];147(8):2199–207. Available from: https://link.springer.com/article/10.1007/s00432-021-03685-5
Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, et al. Long-term risk of colorectal cancer and related death after adenoma removal in a large, community-based population. Gastroenterology. 2020;158(4):884-894.e5.
Cross AJ, Robbins EC, Saunders BP, Duffy SW, Wooldrage K. Higher adenoma detection rates at screening associated with lower long-term colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2022;20(2):e148–67.
Comments (0)